Chun‐Te Chen

Sinotech Genomics (China) — China

Medicine · Health Sciences

25h-index5.3kcitations143works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(19), Seismic Waves and Analysis(13), Chronic Lymphocytic Leukemia Research(12), Seismic Performance and Analysis(11), Lymphoma Diagnosis and Treatment(11)

Publications142 total

HVSR-Based Assessment of Soil Nonlinear Behavior During Strong Ground Motions: Insights from the 3 April 2024 Hualien Earthquake Sequence and Regional Comparisons
Bulletin of the Seismological Society of America·2025· 1 cited
Fast report: strong-motion characteristics of 2025 ML 6.4 Dapu earthquake, Taiwan
Terrestrial Atmospheric and Oceanic Sciences·2025· 3 citedOpen Access
Strong-motion characteristics of two 2022 M 6.5 + disastrous earthquakes in the southern longitudinal valley, Taiwan
Earth Planets and Space·2025· 1 citedOpen Access
BASEMENT EXHUMATION IN LATER STAGES OF ARC-CONTINENT COLLISION REVEALED BY ACTIVE SOURCE SEISMOLOGY: AN EXAMPLE FROM NORTH OF HUALIEN ALONG THE EAST COAST OF TAIWAN
Abstracts with programs - Geological Society of America·2025
Data from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Data from Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
2023Open Access
Supplementary Figure Legend from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Supplementary Figure 3 from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure 3 from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Data from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Supplementary Data from Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
2023Open Access
Supplementary Figure 1 from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Data from Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
2023Open Access
Supplemental Figure 1 from Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Data from Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
2023Open Access
Supplementary Figure Legends 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure 4 from Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
2023Open Access
Supplementary Figures 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Mien‐Chie Hung(29), Weiya Xia(15), Chao‐Kai Chou(13), Heng‐Huan Lee(10), Hirohito Yamaguchi(10), Jung-Mao Hsu(9), Yongkun Wei(9), Hsu-Ping Kuo(8), Ying‐Nai Wang(8), Jennifer L. Hsu(7), Mo Liu(7), Dung‐Fang Lee(7), Yi Du(7), Long‐Yuan Li(6), Gabriel N. Hortobágyi(6), Chun‐Hsiang Kuo(6), Jyun‐Yan Huang(6), Jer-Yen Yang(5), Wen-Hsuan Yu(5), Jennifer L. Hsu(5)